ETAP-LAB, Preclinical CRO, pitching at the TECNIPLAST Scientific Symposium France 2025 next week!
We’re pleased to announce that Sandra Robelet, Business Developer at ETAP-LAB, will be speaking at the TECNIPLAST Symposium, taking place in October 13–15, 2025 in Italy.
📌 When: October 14
🧠Topic: “The Complementarity of NAMs & Animal Models for translational AD’s Drug Development”.
We’ll pitch about:
✔️ Challenges & Opportunities of Alternative Methods (NAMs) at preclinical stage
✔️ The “Brain-on-chip” alternative method (BIO-DIAMOND project*) in drug development stages, and how it can accelerate the time-to-market of drug candidates in the discovery and preclinical phases.
✔️ How combining 2D in vitro models, traditional animal models with innovative alternative approaches can enhance research and therapeutic development in the field of neurodegeneration.
☑️ ETAP-LAB’s holistic approach: translational value at every step, from Target Discovery to Preclinical candidate!
*BIO-DIAMOND project: Carried by an industrial consortium between ETAP-LAB & NETRI, specialist in microfluidic technology. Winner of the “Innovations in biotherapies and bioproduction” call for projects funded by the French government as part of France2030.
